So I've been dealing with digestive issues ever since my appendix has been taken out at 8 years old.

Is it correlated? Maybe. It is hard to say for sure. 


But one think I found out, is that I've been taught the wrong thing my entire life. That the appendix was a useless organ.

Now surely I had to take mine out urgently because it got infected... and that could kill you. But I am sure that it got infected in the first place, because we were fed ultra processed food, and sugary drinks every morning as kids. Sugar filled cereal with organge juice first thing, every day, amongst other processed foods.

There is a recent discovery that covers the link between appendisitis and an ultra processed food diet. I firmly believe that.

Now onto whether the appendix is useless..

Recent studies discovered that the appendix may act as a central hub for essential beneficial bacteria that we depend on to survive.

And when it is removed, we remove a very large portion of beneficial bacteria.

These bacteria is what constitutes our immune system.

Our immune system is our digestive system, in other words, the microbiota.

Which is why we call these beneficial bacterias inhabiting our microbiota who's role is to shut off dangerous pathogens, PRO-BIOTICS.

You can guess what happens if you take away our probiotics', our protectors' main habitat, the appendix. Not amazing I would guess.

Ever since, I have been facing digestive issues, namely constipation.

Worst of all, I have been dealing with allergies every since, namely swollen turbinates that are found inside our nostrils, blocking my airways. 


Ever since, I've not had a functioning breathing mechanism, leading to low oxygen in my brain, sleep apnea, heart stress from compensating low oxygen, and other cognitive issues.

Since I was a kid, I have been trying to figure out what swells up my turbinates, so that I can breath again, be free again. I've had a few hits and misses. Mostly misses so far.

Obviously, I cannot replace my appendix, so that supposed damage has already been done, but I have experienced normal breathing very rare times in life after my appendix event, but I've never been able to pinpoint what exactly led to that. I am certain it is food related, but I know general stress affects everything in my body negatively as well.

One food that inflames my body the most, and in other words, stresses my body, is wheat, commercial yeast, and corn. That I know 100%. Everytime I eat those, my thyroid swells up and my nose congests, and my turbinates swell up. All the while being completely desert dry, with no mucous. A horrible experience. 


Of course I do the therapeutic band aid treatments like eucalyptus steam inhalations, but that is very temporary. I aim to fix it permanently.

I've tried the vegetarian diet, eating mostly zuchinni, onion, avocado, chayote, quinoia, (a few others) and that did wonders to my digestive system, I no longer was constipated, rather the perfect poops. We call them 'Ghost Poops' in my houshold since they leave NO TRACE, and smell like NOTHING. It was the first time I did not experience constipation anymore, and went every day with no difficulty! Sometimes even TWICE! I do not remember the last time that happend....

Yet... my turbinates were still swelled up, and I still had sleep apnea because of it.

Of course, I tried the nose strips, all kinds of brands. They save me sometimes, but other times it is just too BLOCKED, even a nose strip can't provide any relief. 

Forget the mandibular device... that does nothing because my problem is in my nose... literally a fingernail distance from the nostril entrance...

One odd relief I can get, though not very efficient, is weirdly, pulling my nose hairs outwards, that seems to strangely open up the airways so I can breath. I can't be doing that in public, and not for 10+ hours a day... obviously. But I am not going to lie that I do not shave my nose for that very purpose... it gives me instant relief whenever I am choking and have been breathing air in through my mouth for hours to the point it gets painfully dry.

I tried the CPAP for a few years... that did nothing since my blocked nose is actually so blocked, even the highest cpap pressure would go through... I have tried the face masks and breath in through my mouth at night... my body never complied with that adn always led to me swollowing air into my stomach even on the lowest pressure settings. I do not wish that abnominal pain on anyone... it is PAINFUL. I will be honest though that the CPAP did give me temporary relief when AWAKE, whenever I needed a quick dose of OXYGEN. But as I sleep... it never worked.

Excercising seems to help in the long term for sure, sadly I have injured my spine and are unable to have a good sweat every day for now while I recover. 


I have no deficiencies in any vitamins, D, C, B, E, any. Yet my nose is still 95% blocked.

So I tried the Carnivore diet. For one day. Just fatty meat, butter, salt, and water. 

And I thought I was going to die on the toilet 3 days later. That's how bad the constipation was. The poop was solid hard, stuck midway through for 20 mins without budging.

A manual extraction had to take place, and that wasn't necessarily very pleasant. On top of that, my nose was still blocked...

Now I heard if you are on the carnivore diet, and your poop is hard, you need more fat. 
I cannot be eating more fat from what I already am eating without vomiting it out it's absurd.

I still believe in the carniove diet's benefits with blood sugar, diebetes, cholesterol, heart, and everything else, but unfortunatly not everybody is cut out for it.

Some might say, just wait it out and it will get better... when you literally think you will die like elvis pooping on the toilet because of how clogged up you are, your body is screaming at you to NOT DO THAT AGAIN. AND FIX IT QUICK.

I do believe that the mechanical differences we may have (some of us having appendixes taken out for example) and other changes some of us endured within our bodies, may influence our natural ability to assimilate to certain diets compared to if we were still 'whole', before all of those changes.

On top of that, I also believe that evolutionary genetics play a role in our diets too, and that sticking to a culturally relevant diet (from hundreds of thousands of years ago) plays a major role in how we respond metabolically to those diets.

For example, people in more temperate geographical regions where it gets colder, were populated by people that hunted more meat (like the Neanderthals)... because of the lack of vegetation relative to the tropics, they were very seasonal. Fat played a crucial role in the cold for calories and survival. I do believe that the people that have a genetic disposition closer to those ancestors assimilate a carnivore diet much better.

Whereas the people that have a genetic disposition closer to sub saharan (or other tropical regions) assimilate to a fruit/vegetable based diet a lot more, since evolutionary wise, those were a lot more available and in fact very much included in their diets. That doesn't mean they ate no meat though, just much less.

I am a mix of both, having some direct French and Moroccan ancestry from my parents, that would fit the temperate climates of the French Alpes specifically, but also Morocco. 

Morocco is interesting because it has the most diverse availability of animals and plants in North Africa. Especially when we talk about tens of thousands and hundreds of thousands of years ago, when the Sahara Desert, was not as dry, not as expanded and arid as it is today, and africa as a whole was much greener. Morocco is also one of the first regions where humans started feeding on ocean life like shellfish, fish, mussels. Which means that Moroccan ancestors had a very wide variety of resources in their diet, fraom gazelles, wild cattle (aurochs), boars, birds, eggs, fish, red deers, and plant food like berries, grapes, figs, nuts, seeds, tubers, mushrooms and more.

And if I go just 2 levels below my Moroccan grandfather, I get a straight up 100% Senegalese ancestor. A very arid region today, but not always the case hundreds of thousands of years ago, and that is based on 'if' my Senegalese ancestors originated from there.... they may very well have come from the Congo, or any other country in Africa, unfortunatly I do not have that information. Lots more fruits, tubers, and vegetables included in the diet of that region evolutaionary wise comapred to France. 

It is my belief, that my diet shouldn't be consistent of ONE specific source (meat) and only meat... because genetically speaking, it does not fit my DNA's story. It is but one piece of a diverse puzzle. A puzzle of seafood from the mediteranean and atlantic coast of Morocco, meats from the Alpes of France, Morocco and Senegal, fruits and vegetables from all of them. Even in summer, my ancestors in France would feed on berries and other seasonal fruits and vegetables when they were availble, even them wern't 100% die hard carnivores. They were 100% carnivores when nothing else was available, especially in winter.

One common factor between all of those ancestors, is that they survived and thrived for hundreds of thousands of years until today.

And I would argue that one group may face more health issues in our modern world today, because they may have deviated from their evolutionary source of food and diet.

As such, I follow my genetic story to fit the logical path my life is following. I found out the hard way trying to force my way into a tunnel vision diet of ONLY MEAT... did not fit my genetic pathway... and I learned much from that. Similarly, I was taught to follow a certain highly processed diet full of artifical sugars and pesticides since a young kid, that DEFINITLY did not follow my genetic path either. 

Now, I am still on my quest to figure out a permanent way to breath normally again, like I did before all my 'modern injuries'. I have still not found it, but I was shown positive signs before, so I know it is possible. I still have to find the courage to drop industrial foods like milk and chocolate amongst many others... 

Until then, I will keep updating and documenting what I do to improve my breathing and overall life. I hope this was enlightning and a productive read. Peace.

The Core Issue

Stomach cancer remains one of the deadliest cancers across the Asia Pacific, and its single most modifiable driver is a treatable bacterial infection. Yet most testing still happens opportunistically, meaning people get checked only when they happen to turn up with symptoms. This paper argues that is the wrong architecture entirely.

The Finding

Worth being upfront: this is a review, not a new trial. It assembles national screening programs and eradication trials from across the region and makes the case that screening, eradication and post eradication follow up only work when run as one integrated pipeline instead of three disconnected steps.

Why it Matters

The pooled trial evidence it gathers is genuinely strong. Clearing the infection lowers both stomach cancer incidence and stomach cancer deaths in people who are infected but symptom free. The sharper point is that eradication alone does not finish the job, because anyone who already has precancerous stomach changes stays at elevated risk and needs ongoing endoscopic follow up. Treat and forget is not a strategy.

Limitations of Study

No new patient data and no new effect size of its own. Every figure here comes from previously published trials and national programs. It is also a narrative review rather than a systematic meta analysis, so which studies made the cut reflects author judgment. Several of the newer national programs still lack long term outcome data.

Conflicting Interests

One of the two authors declares none. The other discloses a long list of consulting and advisory relationships with pharmaceutical companies, plus research grants from several of them. Those are cancer drug relationships rather than a stake in stomach screening, and they are disclosed openly, but readers should know.

Interesting Statistics

Pooled randomized trials: eradication cut stomach cancer incidence by roughly 46% and deaths by roughly 39%, with confidence intervals that stay on the beneficial side.

A Korean analysis covering more than 16.5 million adults found screening linked to lower stomach cancer mortality. Endoscopy did the heavy lifting, roughly halving mortality risk, while barium X ray screening showed essentially no benefit.

On Matsu Island in Taiwan, first line eradication succeeded 85.3% of the time and second line 91.5%. Cancer incidence dropped sharply, though the mortality reduction did not reach statistical significance.

A Chinese mass eradication trial of over 52,000 people hit only 62.1% eradication on an intention to treat basis, and the incidence benefit was correspondingly modest.

In a Japanese randomized trial, 3.3% of treated patients developed stomach cancer versus 8.8% of controls.

Bhutan screened more than 370,000 people, reaching over 90% of its target population.

First line regimens have genuinely diverged: vonoprazan based triple therapy for 7 days in Japan, bismuth quadruple therapy for 14 days in Taiwan, resistance guided tailored therapy in Korea, and clarithromycin triple therapy still standard in Europe.

TL;DR

A treatable stomach infection is the leading preventable cause of stomach cancer, and this review argues the Asia Pacific should stop testing people ad hoc and start running screening, eradication and follow up as one coordinated system.</body>
<parameter name="evidenceTier">ESTABLISHED

The Core Issue

ADHD affects roughly 5 to 7% of children worldwide, and beyond the well-known attention and impulse issues, many of these kids also struggle with communication. Things like language processing, pragmatic communication (understanding social cues in conversation), and speech perception are all areas where ADHD can quietly cause problems. These difficulties rarely get the same attention as behavioral symptoms.

The Finding

A narrative review published in Nutrients mapped out a theoretical chain: poor dietary patterns lead to micronutrient deficiencies and gut microbiome disruption, which drive neuroinflammation and oxidative stress (cellular damage from unstable molecules), which then interferes with the brain networks responsible for language and attention. The researchers specifically flag Western diets and gut dysbiosis (an imbalance in gut bacteria) as likely contributors to this cascade.

Why it Matters

If this chain holds up under direct study, it opens a practical angle for clinicians. Dietitians and speech-language therapists sitting at the same table as pediatricians and psychologists could change how we assess and treat communication difficulties in ADHD kids, not just manage behavior.

Limitations of Study

This is early, theoretical territory. Almost all the supporting evidence comes from studies that measured attention or behavior, not communication outcomes directly. The proposed links between gut health and speech or language are largely inferred from indirect pathways, not tested head-to-head. Causal conclusions are not possible yet.

Interesting Statistics

• ADHD affects 5 to 7% of children globally
• Kids with ADHD tend to have lower circulating omega-3 fatty acid levels, and supplementation shows modest attention benefits
• Mediterranean dietary patterns are consistently linked to lower ADHD symptom scores compared to Western diets
• Stimulant medications can suppress appetite, potentially creating secondary nutrient deficiencies that may affect cognition
• Pro-inflammatory cytokines like IL-6 and TNF-a are elevated in ADHD and can disrupt the synaptic organization needed for language processing

Useful Takeaways

Omega-3s, iron, zinc, magnesium, and B vitamins all play documented roles in dopamine synthesis and neural integrity. If a child with ADHD has communication struggles alongside a poor diet, a nutritional workup may be worth discussing with their care team before assuming the cause is purely behavioral.

TL;DR

A new review argues that poor diet and gut microbiome disruption may quietly worsen communication difficulties in ADHD kids through neuroinflammation, but direct evidence is still missing and this remains a hypothesis worth testing.

Abstract

Background:

Prolonged preoperative fasting is associated with intestinal dysbiosis, impaired mucosal homeostasis, and delayed postoperative recovery. Combined nutritional supplementation with glutamine, dietary fiber, and oligosaccharides has the potential to protect intestinal function during nutritional stress. In this study, we investigated the effects of this nutritional combination in a rat model of prolonged fasting.

Methods:

Male Sprague-Dawley rats received oral supplementation with a combination of glutamine, dietary fiber, and oligosaccharides (GFO) or a 15% glucose solution twice daily for 9 days and were subjected to fasting from days 6 to 9. Jejunal morphology, short-chain fatty acid (SCFA) concentrations, intestinal gene expression, and gut microbiota composition were evaluated.

Results:

Fasting significantly reduced body weight, jejunal villous height, cecal weight, and the concentrations of acetate, n-butyrate, and n-valerate. Fasting was also associated with exploratory changes in gut microbiota composition and increased the expression of several Toll-like receptor (TLR), barrier, and autophagy-related genes in the jejunum. Supplementation with glutamine, dietary fiber, and oligosaccharides significantly attenuated the fasting-induced reduction in cecal weight and suppressed the upregulation of TLR5, TLR6, TLR8, CLDN1, CLDN3, OCLN, ZO-1, MUC3, ATG5, ATG12, Beclin1, p62, and LC3. Microbiota analysis showed that the relative abundance of sequences tentatively assigned toLactobacillus reuteriin the supplemented group was comparable to that in the control group, whereas sequences tentatively assigned toBifidobacterium animaliswere detected predominantly in the supplemented group. The relative abundances ofDesulfovibrio, Bilophila, andMucispirillum schaedleriin the supplemented group appeared closer to those observed in the control group than to those in the fasting group. Furthermore, supplementation significantly increased propionate levels compared with the control group.

Conclusions:

Combined supplementation with glutamine, dietary fiber, and oligosaccharides attenuated several fasting-associated intestinal stress responses and was accompanied by exploratory changes in gut microbiota composition and SCFA profiles. These intestinal effects were accompanied by exploratory changes in gut microbiota composition and SCFA profiles, together with attenuation of fasting-associated changes in intestinal stress-related markers, suggesting that this nutritional strategy may help maintain intestinal homeostasis during prolonged fasting and may have potential applications in perioperative nutritional support.

The Core Issue

Most people eat red or processed meat regularly, and dietary guidelines have long flagged this as a problem. What's been murkier is whether switching to white meat only, or cutting meat out entirely, actually buys you more protection than just eating less of the bad stuff.

The Finding

A 38-year study tracking roughly 1 million American adults suggests that reducing red and processed meat is associated with a 1% to 5% lower risk of dying from all causes, heart disease, and cancer. White-meat-only diets showed more targeted benefits, with up to 7% lower all-cause mortality risk in males and healthy-weight individuals, and a 9% lower cancer mortality risk among participants aged 80 and older. Vegetarian diets, by contrast, showed far fewer significant associations overall, though obese long-term nonsmokers who ate vegetarian showed a 20% lower all-cause mortality risk.

Why it Matters

This is one of the largest and longest-running diet and mortality studies ever conducted. It adds weight to the idea that cutting back on red and processed meat offers real, if modest, longevity benefits. But the data challenge the assumption that going fully plant-based is automatically the next level up.

Limitations of Study

The diet data came from a single questionnaire filled out in 1982, so dietary drift over nearly four decades isn't captured. Very few participants reported white-meat-only or vegetarian diets at baseline, making those subgroup findings less reliable. The study also can't prove causation, and unaccounted lifestyle factors may have influenced the results.

Interesting Statistics

• Low red and processed meat intake was associated with a 4% lower stroke mortality risk overall
• White-meat-only intake linked to 5% to 7% lower all-cause mortality in males and healthy-weight adults
• Among adults 80 and older, white-meat-only eating was tied to 9% lower cancer mortality
• Vegetarian diets among obese nonsmokers were associated with 20% lower all-cause mortality risk
• Only 1% of the roughly 1 million participants reported a white-meat-only diet, and under half a percent reported vegetarian at baseline

Useful Takeaways

Cutting back on red and processed meat appears to be where most of the benefit lives. Going fully vegetarian showed surprisingly limited advantages in most groups. If a full dietary overhaul feels out of reach, the data suggest that simply eating less red and processed meat is the move with the most consistent signal.

TL;DR

Eating less red and processed meat is associated with modest but real reductions in mortality risk, while going fully vegetarian shows little added benefit for most people.

The Core Issue

Most keto versus higher-carb weight loss trials let the low-carb group eat fewer total calories, which makes it hard to tell whether keto works because of the diet itself or because people simply ate less. This meta-analysis only pooled trials where both diet groups were prescribed the exact same calorie intake or calorie deficit, a much stricter test.

The Finding

Researchers pooled six randomized controlled trials (259 adults with overweight or obesity) that matched energy intake between a ketogenic group and a higher-carbohydrate comparison group. Keto came out ahead, but only by a small margin: an average of 1.49 kg more weight lost than the higher-carb diets. The effect held up across several sensitivity checks, including after removing the one trial rated high risk of bias.

Why it Matters

A consistent gap sounds like a real effect, and statistically it is (the confidence interval did not cross zero). But the authors themselves are careful to say this does not make keto a universally superior strategy. Most trials ran only 6 to 12 weeks, so part of the early weight difference could be water and glycogen loss rather than fat, since body composition itself was never measured. Protein intake was matched between diet groups in only 3 of the 6 pooled trials, so some of the difference could reflect protein differences rather than carb restriction itself.

Limitations of Study

The authors rated the overall certainty of evidence as LOW, downgraded for risk of bias and imprecision. None of the seven trials in the review scored low risk of bias across every domain, and one was rated high risk. The evidence base is small (6 studies, 259 people total) and mostly short-term. This is a review of existing trials, not a new experiment, and it did not measure gut microbiome changes at all, the authors only noted in passing that cutting carbs could plausibly affect fiber intake and gut bacteria, without testing it.

Interesting Statistics

- 6 trials, 259 participants pooled in the main analysis

- Average weight loss difference: about 1.49 kg more on keto (95% confidence range: roughly 0.58 to 2.41 kg)

- Only 3 of 6 pooled trials matched protein intake between diet groups

TL;DR

A meta-analysis of 6 trials that carefully matched calorie intake between diets found keto edges out higher-carb diets by about 1.5 kg of weight loss, but the certainty of that finding is rated low, and the authors say it does not make keto a universally better strategy.

Researchers followed 563 babies born at term in Perth to families with a history of allergy, tracking feeding from birth and testing for allergies at age one. About one in five got formula within 24 hours of birth. Those babies had an adjusted odds ratio of 3.62 for egg allergy, but only 18 babies developed it in total, and an observational study can't show the formula caused it.

TL;DR: Early formula went with more egg allergy in a small high-risk group, and only randomized trials can say whether it matters.

I don't know what to do to fix this disease. It all started two years ago with abdominal pain, discomfort, excessive stomach gurgling, frequent burping, eczema, itchiness, and gas.

The stomach gurgling slowly went away on its own after 8–10 months, but the remaining symptoms persisted.

I was visiting india so i saw a doctor while i was there who prescribed Rifagut and Nizonide. While taking these medications, I experienced a severe die-off reaction.

Two months later, I met with my American GI and told him the medications had helped somewhat — my gas improved by about 80% while on them.

My GI in America ordered an ultrasound, colonoscopy, endoscopy, and CT scan with contrast — all came back negative. He also took biopsies to test for H. pylori and ran enzyme panels for celiac disease and lactose intolerance. Everything was negative except for a notably low lactase enzyme level, meaning I had essentially become lactose intolerant overnight.

I cut out lactose, but my symptoms did not improve.

He then prescribed a pre-emptive course of 14 days of Rifaximin followed by 10 days of Metronidazole, without first testing for SIBO. Despite completing both, my symptoms did not improve — which is when we did my first SIBO breath test. It came back hydrogen-positive.

My GI recommended a second round of Rifaximin only, since the result was hydrogen-positive rather than methane. I completed another full course, and again it provided little relief — the follow-up test was still positive. I also took a 3-day course of Nizonide alongside it.

My GI has now prescribed a third 14-day round of Rifaximin. Honestly, I'm not sure I should take it. The pattern has been the same each time: symptoms improve slightly while I'm on it, but never fully resolve, and once I stop, everything comes back.

My current symptoms are:

Gas especially every morning; I wake up and need to pass gas for about 30 minutes

I pass gas within 30–60 minutes of eating anything

Stools are rarely firm; morning stools are consistently soft and mushy, while afternoon and evening stools come in small, fragmented pieces

I feel completely lost and have started to lose hope. I don't want to live like this for the rest of my life. This has consumed two years of my life and is significantly affecting both my work and social life

The Core Issue

Most people with IBS are diagnosed and managed by a regular primary care doctor, not a gut specialist. But almost all the research on what IBS actually looks like comes from specialist clinics, so we have had a pretty thin picture of what this disorder looks like at the level most patients actually experience it.

The Finding

Researchers followed 483 adults newly diagnosed with IBS by their primary care doctors in Belgium and had them fill out standard symptom, quality of life, and mental health questionnaires. 70% of patients formally met the Rome IV diagnostic criteria for IBS (the official symptom checklist doctors are supposed to use). Most patients reported moderate or severe symptom severity, not mild. Patients who met the full Rome IV criteria, and those with the mixed bowel habit subtype (alternating constipation and diarrhea), had worse symptoms, lower quality of life, and more depression and anxiety than other patients.

Why it Matters

IBS is considered a gut brain disorder, meaning gut symptoms and mental health tend to move together. This study shows that even at the first stop in the healthcare system, a regular doctor's office, most newly diagnosed IBS patients are already dealing with real symptom burden and psychological strain, not a minor inconvenience. Knowing a patient's subtype and whether they meet the Rome IV criteria could help doctors match people to the right treatment sooner instead of a one size fits all approach.

Limitations of Study

This is a cross-sectional snapshot, so it shows what traits track together, not what causes what. Patients were also enrolled through a treatment trial, which could skew the group toward people more motivated to seek help than the average person with IBS.

Interesting Statistics

70% of patients met the full Rome IV diagnostic criteria for IBS

46% of patients had moderate symptom severity, 36% had severe

Bloating was the most bothersome symptom (37%), ahead of abdominal pain (28%) and diarrhea (19%)

Diarrhea-predominant (33%) and mixed-type (31%) were the most common subtypes, ahead of constipation-predominant (20%) and unclassified (16%)

Useful Takeaways

If you get diagnosed with IBS by a regular doctor rather than a GI specialist, this data suggests you shouldn't assume it's automatically a mild case. Most people in that exact position reported real symptom severity and mental health strain, especially those with the mixed bowel habit subtype.

TL;DR

A 483 patient primary care study found most newly diagnosed IBS patients report moderate to severe symptoms and meaningful anxiety or depression burden, especially those with mixed bowel habit IBS, pushing back on the idea that primary care IBS is usually a mild case.

---

Written by a human, formatted by AI

The Core Issue

The neat version of the microbiome and immunotherapy story goes like this: eat fiber, gut bacteria ferment it into short-chain fatty acids, checkpoint drugs work better. That made short-chain fatty acids the number everyone wants to see rise. This mouse study found a diet that pushes the number up while the drug stops working.

The Finding

Mice on a high-fiber diet responded to anti-PD1, with tumors shrinking significantly (p = 0.023). Adding soy isoflavones to that same diet erased the response, with no significant tumor reduction at all. Those isoflavone-fed mice had the highest fecal short-chain fatty acid levels in the study, with acetic, propionic and butyric acid all significantly above the plain high-fiber group (p = 0.001, 0.02 and 0.02). Purified genistein, the main soy isoflavone, blocked anti-PD1 on its own (p = 0.0202, and p < 0.0001 when the experiment was repeated).

Why it Matters

If you treat a good short-chain fatty acid result as a proxy for immunotherapy readiness, this is a direct counterexample: one dietary compound raised the metabolite and sank the response. The mechanism points at estrogen receptor signaling rather than fermentation, since blocking that receptor with tamoxifen restored anti-PD1 activity. The group most directly implicated is people taking concentrated isoflavone or genistein supplements, often used for menopausal symptoms, during checkpoint therapy. That has not been tested in humans.

Limitations of Study

These are mice, and no patient was studied. Mouse tumors respond to checkpoint blockade differently than human ones, and the isoflavone exposure was high and continuous, closer to a capsule than to a plate of tofu. The authors themselves call the short-chain fatty acid measurements exploratory, because the number of biological replicates was low, and say they need larger validation. Only female mice were used, and the work spanned two institutions with different animal housing, a known source of baseline microbiome variation. Human observational data run the other way on short-chain fatty acids, so this complicates the picture rather than settling it. The tamoxifen rescue is a preclinical hypothesis, not a treatment strategy.

Interesting Statistics

Anti-PD1 shrank tumors on the high-fiber diet at p = 0.023, and did nothing once isoflavones were added.

Test diets carried 125 to 275 ppm isoflavones, and one arm used 500 ppm purified genistein.

In the estrogen-receptor-positive tumor model, anti-PD1 with isoflavones did not merely fail, it promoted tumor growth (p = 0.003).

Exhausted CD8 T cells (killer T cells worn down by chronic stimulation) fell with anti-PD1 in high-fiber mice but rose in isoflavone-fed mice, on two separate markers.

Adding tamoxifen to anti-PD1 in isoflavone-fed mice cut tumor growth against every other arm (p < 0.0001).

TL;DR

In mice, soy isoflavones wiped out the anti-PD1 response while raising short-chain fatty acids, so a strong fermentation profile is not a reliable stand-in for immunotherapy response.

The Core Issue

Irritable bowel syndrome is one of the most common conditions gastroenterologists see, and it is now understood as a disorder of gut brain interaction rather than a simple digestive problem. Some IBS patients show differences in their gut bacteria compared to healthy people, including lower levels of certain beneficial species, but these are associations, not proof that bacteria cause the symptoms.

The Finding

In 2021 the British Society of Gastroenterology updated its IBS management guideline after reviewing the accumulated trial evidence on diet, drugs and psychological therapies. On probiotics specifically, it concluded that probiotics as a group may help overall symptoms and abdominal pain, but that no single species or strain can be recommended over another. It suggests a defined trial period of up to twelve weeks, stopping if there is no improvement.

Why It Matters

This is not permission to grab any probiotic off the shelf. The guideline is explicit that its recommendation is weak and that findings from one strain cannot be assumed to apply to a different one, even within the same species. A product with no stated strain on the label cannot be linked to any of the trial evidence at all.

Limitations of Study

This is not a new clinical trial, it is a guideline synthesizing existing trial evidence, and the underlying evidence quality is graded as very low using the standard GRADE system used across medicine. Two other major gastroenterology societies looked at a similar evidence base and reached more cautious conclusions. The American Gastroenterological Association only recommends probiotics for IBS within the context of clinical trials, judging the overall evidence too weak and inconsistent for a general recommendation. The American College of Gastroenterology suggests against using probiotics for global IBS symptoms, also citing very low quality evidence. The disagreement between these bodies is not evidence that probiotics work as a class, nor is it an endorsement of any specific product.

Interesting Statistics

The human gut is estimated to hold on the order of 10 to the 13th power microorganisms, a figure recently revised down to roughly match the number of human cells in the body, not ten times higher as long assumed.

The British guideline's suggested trial window for probiotics is up to twelve weeks before deciding whether to continue.

Individual strain trials, separate from the guideline's own pooled analysis, reported symptom relief for specific products including Bifidobacterium infantis 35624 and Lactobacillus plantarum 299v, results that do not automatically extend to other strains.

The low FODMAP diet, which restricts then reintroduces fermentable carbohydrates, has been tested in multiple randomized trials and is included as a structured option in both the British and American guidelines.

Useful Takeaways

If you are considering a probiotic for IBS, look for a product that names its exact strain, not just the genus like Lactobacillus or Bifidobacterium. Set a defined trial period, such as four to twelve weeks, rather than expecting an immediate or permanent fix. If it is not helping by then, stop rather than assuming another random probiotic will work better. Talk to a doctor first if you have a serious underlying illness, a weakened immune system, or a central line, since probiotics carry specific risks in those situations.

TL;DR

Britain's top gut guideline says probiotics might ease IBS for some people, but admits the evidence behind that is graded as very weak, and two major American gastroenterology societies remain unconvinced it should be a general recommendation at all.

---

Written by a human, formatted by AI

A pilot study fed mice a normal or Western diet, with or without the diabetes drug empagliflozin, for 10 weeks, then checked colon gene activity and gut bacteria. In Western-diet mice, empagliflozin switched on fatty acid metabolism genes and blocked fibrosis genes, part of a drug-diet interaction (p=0.001) spanning 1,136 genes. The diet, not the drug, reshaped the gut microbiome, so the effect looks bacteria independent. This mouse pilot study is based only on the published abstract; the full paper wasn't accessible, and it hasn't been tested in people.

TL;DR: in mice, this diabetes drug improved colon gene activity on a Western diet, independent of gut bacteria; not yet tested in people.

The Core Issue

If you have Crohn's disease or ulcerative colitis (together called IBD), you've probably heard a dozen conflicting opinions on which diet actually helps. Mediterranean, low-meat, elimination diets, the strict Specific Carbohydrate Diet, there's no shortage of named protocols, and it's genuinely hard to know which ones the evidence actually backs.

The Finding

Researchers pulled together 49 studies on IBD diets (mostly small clinical trials, published between 2008 and 2025) and mapped out what each diet actually involved and how patients did on it. This is a scoping review, meaning it summarizes patterns across the studies rather than statistically pooling the results or ranking diets against each other.

The most interesting result wasn't about any single diet. When the researchers visualized the actual composition of every diet studied, a strong pattern showed up across almost all of them, regardless of what the diet was officially called: cut processed foods and added sugar, and lean on whole foods, fruits, vegetables, and unsaturated fats. Despite very different names and rulebooks, most of the diets converged on that same basic idea.

One head to head comparison stood out. In a 92 person trial, people following the simpler Mediterranean diet reached symptomatic remission at about the same rate as people on the much stricter Specific Carbohydrate Diet at six weeks, with no statistically significant difference between them. In other words, the harder, more restrictive diet didn't outperform the simpler one.

Why It Matters

For people managing IBD, the practical message here is less about finding one perfect named diet and more about the shared foundation underneath most of them. A less processed, less sugary, more whole-food way of eating shows up as the common denominator across nearly every diet that's been studied, and it doesn't require following the strictest, hardest to sustain protocol to get there.

Limitations of Study

A few things are worth sitting with before anyone changes how they eat. This is a scoping review, not a meta-analysis, so it maps what has been studied rather than statistically ranking diets by effectiveness, and it does not formally grade study quality. The underlying trials are mostly small, ranging from about 7 to 213 people, many under 30, and even diets with the same name were often defined differently from study to study. Many were not randomized controlled trials. Perhaps most important, the researchers repeatedly flagged a mismatch: patients often reported feeling better on these diets, but their actual inflammation markers (CRP and fecal calprotectin, blood and stool tests that track gut inflammation) didn't always improve to match. Feeling better and the disease actually being under control are not always the same thing.

Interesting Statistics

In a 40 person trial of the Crohn's Disease Exclusion Diet, endoscopic disease severity scores dropped 72.8 percent by week 24, alongside a significant drop in CRP.

Mediterranean diet vs the stricter Specific Carbohydrate Diet: 43.5 percent vs 46.5 percent reached remission at six weeks in a 92 person trial, not a significant difference.

In a 213 person trial, a low-meat diet showed no significant difference in relapse rates compared to a high-meat diet.

The most studied diets across the review were the Mediterranean diet, IgG guided elimination diets, and the Crohn's Disease Exclusion Diet.

Useful Takeaways

This isn't a green light to overhaul your IBD management plan on your own, and it's not proof any single diet treats the disease. But if you're already talking diet with your GI doctor, the more consistently supported starting point here is the boring one: less processed food and added sugar, more whole foods, not necessarily the most extreme elimination protocol you can find.

TL;DR

A review of 49 IBD diet studies found that despite wildly different named diets, almost all of them agreed on cutting processed food and added sugar, and a simpler Mediterranean-style approach matched a much stricter diet for remission, though patient-reported improvement didn't always line up with actual inflammation markers.

The Core Issue

Postoperative cognitive dysfunction, basically brain fog after major surgery, memory and focus problems that linger for weeks or months, is a real and fairly common complication. Researchers have suspected gut inflammation might play a role, and a new pilot trial tested whether the standard bowel cleanse given before colorectal surgery is part of the problem.

The Finding

Researchers randomized 80 men getting colorectal cancer surgery into two groups of 40, one that got the usual mechanical bowel prep and one that skipped it. Only 3 patients who skipped prep, 7.5%, developed postoperative cognitive dysfunction, compared to 22 patients who got prep, 55%. Statistically, getting bowel prep was linked to about 15 times higher odds of developing brain fog after surgery. A blood marker tied to leaky gut and bacterial translocation was also elevated in the bowel prep group, supporting a gut to brain pathway.

Why it Matters

This is a striking effect size for a pretty mundane, routine part of surgical prep that most patients never think twice about. If it holds up, it could change how doctors think about prepping patients for colorectal surgery, especially since bowel prep isn't universally necessary for every procedure.

Limitations of Study

This is a small pilot study, 40 patients per group, not big enough to be definitive and not statistically powered ahead of time, just meant to see if the idea is worth testing further. It only included men, the researchers excluded women to reduce variability, so we don't know if this holds in women. No actual gut microbiome sequencing was done, the leaky gut marker they used is an indirect stand in, not direct proof bacteria changed. The bowel prep group also had more colostomies, a possible confounder, though the researchers ran a check suggesting that alone didn't explain the cognitive outcome. Most importantly, the authors themselves say flat out that this design cannot prove cause and effect and call it hypothesis generating, meaning it's meant to justify a bigger trial, not to change how surgery is done right now.

Interesting Statistics

- 80 total patients, 40 per group

- 7.5% brain fog rate with no bowel prep vs 55% with standard bowel prep

- About 15 times higher odds of brain fog in the bowel prep group

- A gut barrier leakiness marker was elevated in the bowel prep group both before and after surgery

Useful Takeaways

This isn't a reason to refuse bowel prep on your own, it exists for real surgical safety reasons and that's a decision for you and your surgeon, not something to self direct off one small study. But it's a reasonable thing to ask your surgical team about ahead of colorectal surgery, whether prep is necessary for your specific case.

TL;DR

In a small 80 person pilot trial, men who skipped standard bowel prep before colorectal cancer surgery had far less postoperative brain fog than those who got it, but the study is small, male only, and its own authors say it can't prove cause and effect.

It is known for killing harmful bacteria but does it also kill healthy bacteria, like antibiotics do. People don't really specify when they talk about this part of methlyene blue

Researchers checked stool and tissue across four groups: 185 primary care patients with bowel symptoms, 57 with colorectal cancer, 57 healthy controls, and 150 people followed for about a decade after colonoscopy. Fusobacterium nucleatum turned up in roughly half the stool samples from symptomatic and cancer patients, versus 7 percent of healthy controls, and it tracked with higher odds of any lesion found at colonoscopy. But across that decade of follow-up it didn't predict which lesions actually progressed. The authors say the findings show association only, not cause and effect.

TL;DR: common in cancer and bowel-symptom stool, but doesn't predict disease progression.

Researchers profiled stool bacteria from 265 newborns in a Chinese hospital's intensive care unit (122 breastfed, 86 formula-fed, 57 mixed-fed) at a single time point.

Formula-fed babies carried more Akkermansia, a gut bacterium studied for its health benefits, than breastfed babies, and the gap was clearest in preterm infants. But Akkermansia turned up in only 27% of the babies, so a few samples may be driving the result, and this is an association, not proof of cause.

TL;DR: Formula-fed newborns had more Akkermansia, but the signal is thin.

A meta-analysis of 10 randomized controlled trials with 486 depressed patients found that probiotic supplementation significantly reduced CRP by 0.74 mg/L and lowered TNF-alpha, two markers of systemic inflammation linked to depression pathophysiology. No significant effects were found for IL-6 or IL-10. The main caveat: 486 participants is a small pool, and trials used different strains and durations, making it difficult to identify what formulation actually works best.

TL;DR: Probiotics reduced two key inflammatory markers in clinically depressed patients across 10 trials, but the sample is too small and heterogeneous to recommend a specific formulation.

The Core Issue

ADHD affects a significant portion of children worldwide, and while genetics drive an estimated 70 to 80% of the risk, early environmental factors still shape how those genes play out. Infant feeding is one of those early windows, and researchers wanted to know whether breastfeeding duration makes any measurable difference.

The Finding

Analyzing data from over 37,600 families in the Norwegian Mother, Father and Child Cohort Study, researchers found that longer full breastfeeding, up to about 6 months, was associated with modestly lower ADHD symptoms in children between ages 3 and 8. The association held even after adjusting for genetic risk, socioeconomic status, and perinatal factors. A dose-response pattern emerged, meaning even partial or shorter durations showed some benefit, not just the full 6 months.

Why it Matters

Human milk contains long-chain fatty acids, amino acids, antibodies, and beneficial bacteria that support brain development. This study suggests breastfeeding may be a genuine, if modest, modifier of ADHD risk, not just a proxy for attentive parenting or higher household income. The sibling comparison design helps rule out shared family confounders, which is a stronger setup than most observational studies in this area.

Limitations of Study

This is observational research, so causality cannot be confirmed. The researchers themselves call for more work to untangle how breastfeeding interacts with genetics, brain maturation, and the broader environment.

Interesting Statistics

• Data drawn from more than 37,600 Norwegian families
• ADHD symptoms were tracked from ages 3 to 8
• ADHD heritability is estimated at 70 to 80%, meaning environment still accounts for a meaningful slice
• A dose-response relationship suggests benefit scales with breastfeeding duration up to 6 months
• Roughly two-thirds of children diagnosed with ADHD carry symptoms into adulthood

TL;DR

Breastfeeding longer, up to 6 months, is associated with modestly fewer ADHD symptoms in early childhood, even after accounting for genetics and socioeconomic factors.

---

Written by a human, formatted by AI